153 related articles for article (PubMed ID: 38644981)
1. Super High Contrast USPIO-Enhanced Cerebrovascular Angiography Using Ultrashort Time-to-Echo MRI.
Timms L; Zhou T; Qiao J; Gharagouzloo C; Mishra V; Lahoud RM; Chen JW; Harisinghani M; Sridhar S
Int J Biomed Imaging; 2024; 2024():9763364. PubMed ID: 38644981
[TBL] [Abstract][Full Text] [Related]
2. Ferumoxytol-enhanced ultrashort TE MRA and quantitative morphometry of the human kidney vasculature.
Timms L; Zhou T; Lyu Y; Qiao J; Mishra V; Lahoud RM; Jayaraman GV; Allegretti AS; Drew D; Seethamraju RT; Harisinghani M; Sridhar S
Abdom Radiol (NY); 2021 Jul; 46(7):3288-3300. PubMed ID: 33666735
[TBL] [Abstract][Full Text] [Related]
3. Quantitative contrast-enhanced MRI with superparamagnetic nanoparticles using ultrashort time-to-echo pulse sequences.
Gharagouzloo CA; McMahon PN; Sridhar S
Magn Reson Med; 2015 Aug; 74(2):431-41. PubMed ID: 25168606
[TBL] [Abstract][Full Text] [Related]
4. Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.
Gitsioudis G; Fortner P; Stuber M; Missiou A; Andre F; Müller OJ; Katus HA; Korosoglou G
Int J Cardiovasc Imaging; 2016 Nov; 32(11):1645-1655. PubMed ID: 27535040
[TBL] [Abstract][Full Text] [Related]
5. A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI.
Prince MR; Zhang HL; Chabra SG; Jacobs P; Wang Y
J Xray Sci Technol; 2003 Jan; 11(4):231-40. PubMed ID: 22388293
[TBL] [Abstract][Full Text] [Related]
6. Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.
Krishnam MS; Tomasian A; Deshpande V; Tran L; Laub G; Finn JP; Ruehm SG
Invest Radiol; 2008 Jun; 43(6):411-20. PubMed ID: 18496046
[TBL] [Abstract][Full Text] [Related]
7. Detection of iron oxide nanoparticle (IONP)-labeled stem cells using quantitative ultrashort echo time imaging: a feasibility study.
Athertya JS; Akers J; Sedaghat S; Wei Z; Moazamian D; Dwek S; Thu M; Jang H
Quant Imaging Med Surg; 2023 Feb; 13(2):585-597. PubMed ID: 36819276
[TBL] [Abstract][Full Text] [Related]
8. Feasibility Study of Ferumoxtyol for Contrast-enhanced MRI of Retroplacental Clear Space Disruption in Placenta Accreta Spectrum (PAS).
Badachhape AA; Burnett B; Bhandari P; Devkota L; Bhavane R; Ghaghada KB; Yallampalli C; Fox KA; Annapragada AV
medRxiv; 2023 Mar; ():. PubMed ID: 36993653
[TBL] [Abstract][Full Text] [Related]
9. Iron Sucrose as MRI Contrast Agent in Ischemic Stroke Model.
Wu S; Zhang H; Wang J; Li X; Gao X; Fang Z; Qu J; Wu Y; Ren Y; Rui W; Zhang J; Yao Z
J Magn Reson Imaging; 2020 Sep; 52(3):836-849. PubMed ID: 32112623
[TBL] [Abstract][Full Text] [Related]
10. USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.
Sigovan M; Gasper W; Alley HF; Owens CD; Saloner D
Radiology; 2012 Nov; 265(2):584-90. PubMed ID: 22875796
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical evaluation of a nanoparticle-based blood-pool contrast agent for MR imaging of the placenta.
Ghaghada KB; Starosolski ZA; Bhayana S; Stupin I; Patel CV; Bhavane RC; Gao H; Bednov A; Yallampalli C; Belfort M; George V; Annapragada AV
Placenta; 2017 Sep; 57():60-70. PubMed ID: 28864020
[TBL] [Abstract][Full Text] [Related]
12. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
[TBL] [Abstract][Full Text] [Related]
13. High spatial resolution contrast-enhanced MR angiography of the supraaortic arteries using the quadrature body coil at 3.0T: a feasibility study.
Willinek WA; Bayer T; Gieseke J; von Falkenhausen M; Sommer T; Hoogeveen R; Wilhelm K; Urbach H; Schild HH
Eur Radiol; 2007 Mar; 17(3):618-25. PubMed ID: 16944161
[TBL] [Abstract][Full Text] [Related]
14. [Gadolinium-enhanced magnetic resonance angiography of abdominal blood vessels].
Stehling MK; Holzknecht N; Laub G
Radiologe; 1997 Jul; 37(7):539-46. PubMed ID: 9340687
[TBL] [Abstract][Full Text] [Related]
15. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla.
Allkemper T; Heindel W; Kooijman H; Ebert W; Tombach B
Invest Radiol; 2006 Feb; 41(2):97-104. PubMed ID: 16428979
[TBL] [Abstract][Full Text] [Related]
16. Comparison of contrast-enhanced T1-weighted FLAIR with BLADE, and spin-echo T1-weighted sequences in intracranial MRI.
Alkan O; Kizilkiliç O; Yildirim T; Alibek S
Diagn Interv Radiol; 2009 Jun; 15(2):75-80. PubMed ID: 19517375
[TBL] [Abstract][Full Text] [Related]
17. Noncontrast 3D steady state free precession magnetic resonance angiography of the thoracic central veins using nonselective radiofrequency excitation over a large field of view: initial experience.
Tomasian A; Lohan DG; Laub G; Singhal A; Finn JP; Krishnam MS
Invest Radiol; 2008 May; 43(5):306-13. PubMed ID: 18424951
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ferumoxytol- and gadolinium chelate-enhanced MRI for assessment of sarcomas in children and adolescents.
Siedek F; Muehe AM; Theruvath AJ; Avedian R; Pribnow A; Spunt SL; Liang T; Farrell C; Daldrup-Link HE
Eur Radiol; 2020 Mar; 30(3):1790-1803. PubMed ID: 31844962
[TBL] [Abstract][Full Text] [Related]
19. Ferumoxytol-enhanced magnetic resonance angiography provides comparable vascular conspicuity to CT angiography in dogs with intrahepatic portosystemic shunts.
Wilson S; Culp WTN; Wisner ER; Cissell DD; Finn JP; Zwingenberger AL
Vet Radiol Ultrasound; 2021 Jul; 62(4):463-470. PubMed ID: 33634935
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
